Effect of Endurance Training on Serum Levels of Alanine Aminotransferase, Aspartate Aminotransferase, and Resistin in Men with Non-Alcoholic Fatty Liver Disease

Document Type : Original article

Authors

1 PhD Candidate of Exercise Physiology, Department of Physical Education and Sport Sciences, Faculty of Education and Psychology, University of Mohaghegh Ardabili, Ardabil, Iran

2 Professor of exercise physiology, Department of Physical Education and Sport Sciences, Faculty of Education and Psychology, Univercity of Mohaghegh Ardabili, Ardabil, Iran

3 Associate Professor, Department of Internal Diseases, Ardabil University of Medical Sciences, Ardabil, Iran.

4 Assistant Professor, Department of Physical Education and Sport Sciences, Faculty of Education and Psychology , Univercity of Mohaghegh Ardabili, Ardabil, Iran.

5 Assistant Professor, Department of Radiology, Ardabil University of Medical Sciences, Ardabil, Iran

Abstract

Background and Aims: Non-alcoholic fatty liver disease is a public health problem in the world. Exercise is a first-line therapy for patients with non-alcoholic fatty liver disease. Therefore, the present study was conducted to determine the effect of eight weeks of endurance training on serum levels of alanine aminotransferase, aspartate aminotransferase, and resistin in men with non-alcoholic fatty liver disease.
Materials and Methods: A total of 23 patients with non-alcoholic fatty liver disease were selected following purposeful sampling in the present quasiexperimental study. Participants were randomly divided into two groups: endurance training group (n=12) and control group (n=11). The endurance training program included moderate intensity training with 60-75% of maximal heart rate for 45 min/session, 3 times/week for 8 weeks. At both baseline and completion of the eighth week, blood samples were obtained from all the participants. Data were analyzed running Shapiro-Wilk test and dependent and independent t-tests at the significant level of pResults: In the current study, eight weeks of endurance training resulted in a significant decrease in serum levels of alanine aminotransferase, aspartate aminotransferase, and resistin in males with non-alcoholic fatty liver(α<0.05).
Conclusion: According to the findings, endurance training may improve the serum levels of alanine aminotransferase, aspartate aminotransferase, and resistin in men with non-alcoholic fatty liver disease. Therefore, to reduce the dependent risk factors of non-alcoholic fatty liver disease, this therapeutic intervention seems to be beneficial.

Keywords

Main Subjects

References

  1. Polyzos SA, Kountouras J, Mantzoros CS. Adipokines in nonalcoholic fatty liver disease. Metabolism. 2016; 65(8):1062–79. ##
  2. Di Costanzo A, D’Erasmo L, Polimeni L, Baratta F, Coletta P, Di Martino M, et al. Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storage. Atherosclerosis. 2017; 257:232–9. ##
  3. Katsiki N, Mikhailidis DP, Mantzoros CS. Non-alcoholic fatty liver disease and dyslipidemia: An update. Metabolism. 2016; 65(8):1109–23. ##
  4. Lonardo A, Sookoian S, Pirola CJ, Targher G. Non-alcoholic fatty liver disease and risk of cardiovascular disease. Metabolism. 2016; 65(8):1136–50. ##
  5. Chen SC-C, Tsai SP, Jhao J-Y, Jiang W-K, Tsao CK, Chang L-Y. Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults. Sci Rep. 2017; 10(1):4649. ##
  6. Zar A, Hosseini SA, Homaion A. Qom Univ Med Sci 2016 September Original Article Effect of Eight-Week Aquagymnastic Training on Liver Enzymes and Lipid Profile of Middle-Aged Women. Qom Univ Med Sci J. 2016; 10(7):29-37. ##
  7. Weng SF, Kai J, Guha IN, Qureshi N. The value of aspartate aminotransferase and alanine aminotransferase in cardiovascular disease risk assessment. Open Heart. 2015; 2(1):1-10. ##
  8. Gruzdeva O, Uchasova E, Belik E, Dyleva Y, Shurygina E, Barbarash O. Lipid, adipokine and ghrelin levels in myocardial infarction patients with insulin resistance. BMC Cardiovasc Disord. 2014; 14(1):1-7. ##
  9. Reilly MP, Lehrke M, Wolfe ML, Rohatgi A, Lazar MA, Rader DJ. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation. 2005; 111(7):932–9. ##

10. Chen C, Jiang J, Lü J, Chai H, Wang X, Lin PH, et al. Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells. 2010; 193–201. ##

11. Jamaluddin MS, Weakley SM, Yao Q, Chen C. Resistin: Functional roles and therapeutic considerations for cardiovascular disease. Br J Pharmacol. 2012; 165(3):622–32. ##

12. Codoner-Franch P, Alonso-Iglesias E. Resistin: Insulin resistance to malignancy. Clin Chim Acta. 2015; 438(1):46–54. ##

13. Hannah WN, Harrison SA. Lifestyle and dietary interventions in the management of nonalcoholic fatty liver disease. Clin Liver Dis. 2016; 61(5):1365–74. ##

14. Pugh CJA, Spring VS, Kemp GJ, Richardson P, Shojaee-Moradie F, Umpleby AM, et al. Exercise training reverses endothelial dysfunction in nonalcoholic fatty liver disease. Am J Physiol Heart Circ Physiol. 2014; 307(9):1298-306. ##

15. Marcelino-Rodriguez I, Almeida Gonzalez D, Aleman-Sanchez JJ, Brito Díaz B, Rodriguez Perez M del C, Gannar F, et al. Inverse association of resistin with physical activity in the general population. PLoS One. 2017; 12(8):0182493. ##

16. Ben Ounis O, Elloumi M, Lac G, Makni E, Van Praagh E, Zouhal H, et al. Two-month effects of individualized exercise training with or without caloric restriction on plasma adipocytokine levels in obese female adolescents. Ann Endocrinol. 2009; 70(4):235–41. ##

17. Gondim OS, De Camargo VTN, Gutierrez FA, De Oliveira Martins PF, Passos MEP, Momesso CM, et al. Benefits of regular exercise on inflammatory and cardiovascular risk markers in normal weight, overweight and obese adults. PLoS One. 2015; 10(10):1–14. ##

18. Arbabi A. The effect moderate exercise on the plasma level of C-reactive protein , leptin , adiponectin and resistin and their relationship with body fat percentage in un-trained males. Int J Sport Stud. 2015; 5(3):280–6. ##

19. Samadiyan Z, Tofighi A, Mehdizadeh A. The effect of 12 weeks of combined exercises on serum resistin levels and glycemic indices in obese women with type 2 diabetes. Iranian J of Diab and Lip. 1392; 12(6):524-33. [In Persian] ##

20. Shamsoddini A, Sobhani V, Ghamar Chehreh ME, Alavian SM, Zaree A. Effect of Aerobic and Resistance Exercise Training on Liver Enzymes and Hepatic Fat in Iranian Men With Nonalcoholic Fatty Liver Disease. Hepat Mon. 2015; 15(10):31434. ##

21. Nobahar M. The effect of increasing exhausting exercise on some enzymes of active muscle damage index. Met and exer J. 1391; 2(1):1-12. [In Persian] ##

22. Rezaei M, Rahimi E, Bordbar S NS. The Effects of Three Sessions of Running on a Negative Slope on Serum Levels of Liver Enzymes in Adult Male Rats. Zahedan J Res Med Sci. 2013; 15(5):47–9. ##

23. LaBrecque DR, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Penaranda MM, Ramos JF, Sarin S, Stimac D, Thomson AB, UmarM, Krabshuis J LA. World Gastroenterology Organisation Global Guidelines: Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. J Clin Gastroenterol. 2014; 48(6):467–73. ##

24. Farzanegi P, Pour Amin Z HM. Changes of Liver Trans-Aminases after a Period of Selected Aerobic Training in Postmenopausal Women. MLJ. 2014; 8(1):22–8. [In Persian] ##

25. Mikami T, Sumida S, Ishibashi Y, Ohta S. Endurance exercise training inhibits activity of plasma GOT and liver caspase-3 of mice exposed to stress by induction of heat shock protein 70. J Appl Physiol. 2004; 96(5):1776–81. ##

26. Haus JM, Solomon TPJ, Kelly KR, Fealy CE, Kullman EL, Scelsi AR, et al. Improved hepatic lipid composition following short-term exercise in nonalcoholic Fatty liver disease. J Clin Endocrinol Metab. 2013; 98(7):1181-8. ##

27. Hallsworth K, Avery L, Trenell MI. Targeting lifestyle behavior change in adults with NAFLD during a 20-min consultation: summary of the dietary and exercise literature. Curr Gastroenterol Rep. 2016; 18(3):11.1-7. ##

28. Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. I. Performance characteristics of laboratory tests.. Clin Chem. 2000; 46(12):2027–49. ##

29. Aghapour A, Farzanegi P. Effect of six-week aerobic exercise on Chemerin and Resistin concentration in hypertensive postmenopausal women. Electron Physician. 2013; 5(1):623–30. ##

30. Maroto-S??nchez B, Lopez-Torres O, Palacios G, Gonz?lez-Gross M. What do we know about homocysteine and exercise? A review from the literature. Clin Chem Lab Med. 2016; 54(10):1561–77. ##

31. Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. J Hepatol. 2017;66(1): 142–52. ##

32. Berzigotti A, Saran U, Dufour J-F. Physical activity and liver diseases. Hepatology. 2016; 63(3):2–31. ##

33. Ceddia DMS-K and RB. Exercise-Mediated Effects on White and Brown Adipose Tissue Plasticity and Metabolism. Exerc Sport Sci Rev. 2016; 44(1):37–44. ##

34. Guo R, Liong E, So K, Fung M, Tipoe G. Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int. 2015; 14(2):139–44. ##

The Scientific Journal of Rehabilitation Medicine
Volume 7, Issue 3
September and October 2018
Pages 125-132

Files

History

  • Receive Date: 05 October 2017
  • Revise Date: 04 December 2017
  • Accept Date: 17 December 2017
  • First Publish Date: 23 September 2018

Share

How to cite

Statistics